Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (12): 1110-1113.doi: 10.35541/cjd.20210677

• Reviews • Previous Articles     Next Articles

Treatment of chronic inducible urticaria

Chen Qiquan, Song Zhiqiang   

  1. Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing 400038, China
  • Received:2021-09-15 Revised:2021-10-11 Online:2021-12-15 Published:2021-12-01
  • Contact: Song Zhiqiang
  • Supported by:
    National Natural Science Foundation of China(82003359)

Abstract: 【Abstract】 At present, the pathogenesis of chronic inducible urticaria (CIndU) is not completely clear, and it is often difficult to achieve satisfactory symptom control only by avoiding triggers. In recent years, some progress has been made in the treatment of CIndU in China and other countries, such as traditional antihistamines, non-antihistamines, biological agents, small-molecule targeted drugs and other drug treatments, as well as physical therapies such as trigger-point desensitization therapy. This review comprehensively and systematically outlines and summarizes relevant progress.

Key words: Urticaria, Therapy, Histamine antagonists, Biological agents, Chronic inducible urticaria, Physical urticaria